Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06682949 · ClinicalTrials.gov registry record · NA
Daily Routines, Executive Functioning & ADHD
A NA study of Attention Deficit Disorder With Hyperactivity (ADHD), sponsored by Cori Manning.
- Recruiting
- Registry status
- NA
- Development phase
- 25
- Enrollment target
- 1
- Study location
NCT06682949: Recruiting NA study of Attention Deficit Disorder With Hyperactivity (ADHD), sponsored by Cori Manning.
NCT06682949 is a NA study of Attention Deficit Disorder With Hyperactivity (ADHD) that is actively recruiting participants, run by Cori Manning. The registered enrollment target is 25 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06682949, a NA study of Attention Deficit Disorder With Hyperactivity (ADHD), is actively recruiting participants, sponsored by Cori Manning.
- RECRUITING
- Registry status
- NA
- Development phase
- 25 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to learn adjusting daily or nightly routines improves executive functioning in youth with ADHD. It will also learn about the acceptability of the intervention. The main questions it aims to answer are: 1. Does the intervention improve sleep for youth with ADHD? 2. Does the intervention improve areas of executive functioning for youth with ADHD? 3. Is this an acceptable intervention for youth with ADHD? Researchers will compare the two intervention conditions to see if their are impacts in executive functioning and sleep. Participants will: Complete cognitive testing, executive function tasks, questionnaires, and an interview at baseline and at one month Wear an actigraph watch for one month Bring a parent with them to three meetings Complete daily sleep diaries for one month
Primary Outcome
Actigraphy data will be used to determine changes in sleep duration pre and post intervention. Average total sleep time during the baseline period will be compared to average total sleep time during the intervention period.
Conditions Studied
Interventions
- BEHAVIORAL Sleep Extension
- BEHAVIORAL Daytime Routine
Study Locations (1)
Arizona
- University of Arizona - College of Education - Tucson
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2024-11-04 |
| Est. Completion | 2025-06 |
| Phase | NA |
What NCT06682949 shows while recruiting
NCT06682949 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 25 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Attention Deficit Disorder With Hyperactivity (ADHD) appearing as the primary indexed condition, and to 2 interventions - of which Sleep Extension is the first listed.
NCT06682949 reports a single indexed study location in Arizona.
Frequently Asked Questions
What is clinical trial NCT06682949 about?
NCT06682949 is a clinical study titled "Daily Routines, Executive Functioning & ADHD". The goal of this clinical trial is to learn adjusting daily or nightly routines improves executive functioning in youth with ADHD. It will also learn about the acceptability of the intervention. The main questions it aims to answer are: 1. Does the intervention improve sleep for youth with ADHD? 2...
What is the current status of trial NCT06682949?
This trial is currently recruiting. It is a NA study. The enrollment target is 25 participants. The study started on 2024-11-04. Estimated completion is 2025-06.
What conditions does trial NCT06682949 study?
This clinical trial studies the following conditions: Attention Deficit Disorder With Hyperactivity (ADHD).
What interventions are being tested in trial NCT06682949?
The interventions under investigation include: Sleep Extension (BEHAVIORAL), Daytime Routine (BEHAVIORAL).
Who is sponsoring clinical trial NCT06682949?
This trial is sponsored by Cori Manning, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06682949 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Attention Deficit Disorder With Hyperactivity (ADHD)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06682949's enrollment target sits among peer trials
25 1712th of 2000 higher than 265 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01166854 · 25 participants
Characterization of Familial Myopathy and Paget Disease of Bone
- NCT01913106 · 25 participants · Phase 1
HSV-tk + Valacyclovir Therapy in Combination With Brachytherapy for Recurrent Prostate Cancer
- NCT02138669 · 25 participants · NA
Intacs Prescription Inserts for Keratoconus Patients
- NCT02174549 · 25 participants · Phase 1
Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI